We are live on
!
Find out more
Sit Investment Associates Portfolio holdings
AUM
$5.28B
Turnover
14.52%
1-Year Est. Return
14.42%
This Fund
S&P 500
This Quarter
Est. Return
-1.03%
1 Year Est. Return
+14.42%
3 Year Est. Return
+49.57%
5 Year Est. Return
+37.84%
10 Year Est. Return
+154.77%
AUM
$5.46B
AUM Growth
-$310M
(-5.4%)
Cap. Flow
-$240M
Cap. Flow
% of AUM
-4.39%
Top 10 Holdings %
Top 10 Hldgs %
17.87%
Holding
522
New
96
Increased
123
Reduced
173
Closed
37
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$46.9M |
| 2 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$27.2M |
| 3 |
Visa
V
|
+$22.8M |
| 4 |
Delta Air Lines
DAL
|
+$21.2M |
| 5 |
Brixmor Property Group
BRX
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRA
Diversified Real Asset Income Fd
DRA
|
+$26.4M |
| 2 |
Zimmer Biomet
ZBH
|
+$22.5M |
| 3 |
STJ
St Jude Medical
STJ
|
+$22M |
| 4 |
Johnson & Johnson
JNJ
|
+$19.8M |
| 5 |
Helmerich & Payne
HP
|
+$19.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.43% |
| 2 | Miscellaneous | 14.62% |
| 3 | Financials | 12.94% |
| 4 | Technology | 12.44% |
| 5 | Industrials | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Medtronic
MDT
$121B
| $134M | 2.46% |
1,809,975
-9,151
| -0.5% | -$699K |
2014 Q1
5 quarters
|
|
2
Apple
AAPL
$4.99T
| $114M | 2.08% |
3,630,088
-210,200
| -5% | -$6.72M |
2013 Q2
8 quarters
|
|
3
Home Depot
HD
$308B
| $108M | 1.98% |
971,005
-40,283
| -4% | -$4.51M |
2013 Q2
8 quarters
|
|
4
Microsoft
MSFT
$3.9T
| $101M | 1.85% |
2,287,080
-228,160
| -9% | -$10.4M |
2013 Q2
8 quarters
|
|
5
PepsiCo
PEP
$179B
| $94.8M | 1.74% |
1,015,130
-51,060
| -5% | -$4.88M |
2013 Q2
8 quarters
|
|
6
Honeywell
HON
$67.1B
| $93.7M | 1.72% |
1,022,225
-210,150
| -17% | -$19.6M |
2013 Q2
8 quarters
|
|
7
JPMorgan Chase
JPM
$899B
| $92.2M | 1.69% |
1,360,880
-141,290
| -9% | -$9.22M |
2013 Q2
8 quarters
|
|
8
Verizon
VZ
$186B
| $85.3M | 1.56% |
1,831,150
-169,970
| -8% | -$8.32M |
2013 Q2
8 quarters
|
|
|
9
Target
TGT
$69.9B
| $77.5M | 1.42% |
949,841
+579,104
| +156% | +$46.9M |
2013 Q2
8 quarters
|
|
10
Intel
INTC
$475B
| $75.6M | 1.38% |
2,484,060
+38,585
| +2% | +$1.25M |
2013 Q2
8 quarters
|
|
11
Broadcom
AVGO
$1.58T
| $74.9M | 1.37% |
5,634,900
-499,800
| -8% | -$6.55M |
2013 Q2
8 quarters
|
|
12
CVS Health
CVS
$119B
| $73.8M | 1.35% |
703,475
-97,125
| -12% | -$9.92M |
2013 Q2
8 quarters
|
|
|
13
Johnson & Johnson
JNJ
$615B
| $71.7M | 1.31% |
735,235
-197,783
| -21% | -$19.8M |
2013 Q2
8 quarters
|
|
14
Pfizer
PFE
$168B
| $67.8M | 1.24% |
2,132,516
+75,709
| +4% | +$2.47M |
2013 Q2
8 quarters
|
|
15
Procter & Gamble
PG
$369B
| $65.6M | 1.2% |
838,795
+54,430
| +7% | +$4.38M |
2013 Q2
8 quarters
|
|
16
UnitedHealth
UNH
$361B
| $64.6M | 1.18% |
529,450
+27,200
| +5% | +$3.22M |
2013 Q2
8 quarters
|
|
17
Becton Dickinson
BDX
$51.9B
| $64.5M | 1.18% |
466,964
+15,938
| +4% | +$2.2M |
2014 Q1
5 quarters
|
|
|
TWX
18
DELISTED
Time Warner Inc
TWX
| $61M | 1.12% |
698,215
-43,125
| -6% | -$3.68M |
2013 Q4
6 quarters
|
|
19
Applied Materials
AMAT
$328B
| $59.7M | 1.09% |
3,106,765
+812,405
| +35% | +$16.7M |
2013 Q2
8 quarters
|
|
20
Gilead Sciences
GILD
$193B
| $58.4M | 1.07% |
498,725
-95,670
| -16% | -$10.5M |
2013 Q2
8 quarters
|
|
21
AbbVie
ABBV
$505B
| $57.1M | 1.05% |
849,470
-39,321
| -4% | -$2.57M |
2015 Q1
1 quarter
|
|
22
Cardinal Health
CAH
$58.8B
| $56.2M | 1.03% |
671,605
-88,655
| -12% | -$7.83M |
2013 Q2
8 quarters
|
|
23
Walmart Inc
WMT
$941B
| $55.1M | 1.01% |
2,331,705
+641,925
| +38% | +$16.4M |
2015 Q1
1 quarter
|
|
24
Macy's
M
$6.27B
| $53.8M | 0.99% |
797,101
-237,969
| -23% | -$16.1M |
2013 Q2
8 quarters
|
|
25
Kimberly-Clark
KMB
$34.9B
| $53.6M | 0.98% |
506,255
+49,850
| +11% | +$5.43M |
2014 Q4
2 quarters
|
|
Similar funds
WAP
Sit Investment Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Sit Investment Associates held 522 positions worth $5.46B, down 5.4% from $5.77B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Sit Investment Associates withdrew a net $240M in Q2 2015, closing 37 positions and reducing 173 holdings. Its most notable exit was Cummins, an estimated $19.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Sit Investment Associates opened a new position in Teva Pharmaceutical Industries Limited worth $26.1M.
- Sit Investment Associates's largest Q2 2015 buy was Teva Pharmaceutical Industries Limited: 441,660 shares worth $26.1M.
- Sit Investment Associates added most to Target in Q2 2015, an estimated $46.9M increase.
- Sit Investment Associates's biggest Q2 2015 reduction was Diversified Real Asset Income Fd, cutting an estimated $26.4M.
- Sit Investment Associates fully exited Cummins in Q2 2015, selling an estimated $19.5M.
- Sit Investment Associates's ten largest holdings make up 18% of its $5.46B portfolio in Q2 2015.
- Sit Investment Associates opened 96 new positions and closed 37 in Q2 2015.
- Sit Investment Associates's portfolio value fell 5.4% quarter-over-quarter to $5.46B.
Based on Sit Investment Associates's 13F filing for Q2 2015, filed 20 Jul 2015.